Lipigon Pharmaceuticals AB (FRA:9RP) Total Liabilities: €0.35 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Lipigon Pharmaceuticals AB Total Liabilities?

Lipigon Pharmaceuticals AB FRA:9RP Total Liabilities is €0.35 Mil as of Dec. 2025. The stock has 2 warning signs investors should review.

Lipigon Pharmaceuticals AB's Total Liabilities for the quarter that ended in Dec. 2025 was €0.35 Mil.

Lipigon Pharmaceuticals AB's quarterly Total Liabilities declined from Jun. 2025 (€0.37 Mil) to Sep. 2025 (€0.27 Mil) but then increased from Sep. 2025 (€0.27 Mil) to Dec. 2025 (€0.35 Mil).

Lipigon Pharmaceuticals AB's annual Total Liabilities increased from Dec. 2023 (€0.46 Mil) to Dec. 2024 (€0.61 Mil) but then declined from Dec. 2024 (€0.61 Mil) to Dec. 2025 (€0.35 Mil).

Lipigon Pharmaceuticals AB Total Liabilities Historical Data

* Premium members only.

The historical data trend for Lipigon Pharmaceuticals AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lipigon Pharmaceuticals AB Total Liabilities Chart

Lipigon Pharmaceuticals AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial 0.63 0.63 0.46 0.61 0.35

Lipigon Pharmaceuticals AB Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.61 0.66 0.37 0.27 0.35

Lipigon Pharmaceuticals AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Lipigon Pharmaceuticals AB's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.351+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.35

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=1.078-0.727
=0.35

Lipigon Pharmaceuticals AB's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.351+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.35

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=1.078-0.727
=0.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €0.35 Mil mean?
Lipigon Pharmaceuticals AB (FRA:9RP) has a Total Liabilities of €0.35 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Lipigon Pharmaceuticals AB and its competitors.
Is Lipigon Pharmaceuticals AB's Total Liabilities too high?
Lipigon Pharmaceuticals AB's current Total Liabilities is €0.35 Mil.
How does Lipigon Pharmaceuticals AB's Total Liabilities compare to VRTX and REGN?
Lipigon Pharmaceuticals AB's Total Liabilities of €0.35 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Lipigon Pharmaceuticals AB and its competitors. Lipigon Pharmaceuticals AB's current Total Liabilities is €0.35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lipigon Pharmaceuticals AB stock overvalued right now?
Lipigon Pharmaceuticals AB (FRA:9RP) has a current Total Liabilities of €0.35 Mil. The current Total Liabilities is €0.35 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Lipigon Pharmaceuticals AB (FRA:9RP), the current Total Liabilities is €0.35 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lipigon Pharmaceuticals AB Business Description

Address Tvistevagen 48 C, Umea, SWE, 90736
Lipigon Pharmaceuticals AB develops medicines for diseases caused by disorders of the body's handling of fats. It focuses on orphan drugs for unusual diseases where there is no adequate treatment.